Seeking Alpha
View as an RSS Feed

Stanley Barton  

View Stanley Barton's Comments BY TICKER:
Latest  |  Highest rated
  • Ambarella: 5 Different Insiders Have Sold Shares This Month [View article]
    Just announced blowout earnings and institutional ownership is up 6%. Look at how many shares the insiders are holding on to...
    Dec 19, 2013. 06:19 PM | 6 Likes Like |Link to Comment
  • Refreshing Our Best-Of-The-Best Dividend Portfolio [View article]
    galacianova,

    It is bigger than I expected, but it is not a "return of capital." Obviously, that is a good sign, and I think the managers of this fund have proven to be better than average in their sector. BME sells for about $1.40 less than the NAV, so there is some room for appreciation just catching up to NAV...in the past, at times this one sold at a premium, instead of a discount.

    Good luck and happy holidays,

    Stan
    Dec 17, 2013. 12:19 PM | Likes Like |Link to Comment
  • Refreshing Our Best-Of-The-Best Dividend Portfolio [View article]
    galicianova,

    If you buy now, theoretically you are buying the dividend and paying taxes on that. Last year and somewhat the year before the stock dropped on ex-divvy day and drifted lower until the actual payment, after which it shot up (possibly from dividend reinvestment). If history repeats, the timing of a future purchase would be sometimes after ex-dividend day and before the payment day. Of course, a Santa Clause rally in the healthcare sector would help BME regardless of dividend.

    Hope that helps.

    Stan
    Dec 17, 2013. 11:06 AM | Likes Like |Link to Comment
  • The Street's Ag Blues Seem To Be Weighing On American Vanguard [View article]
    Thanks for the article.

    AVD has proven and effective management. If you think that the global food situation is an important long-term macro factor, this is a way to get exposure to that in a portfolio.
    Dec 12, 2013. 11:58 AM | 1 Like Like |Link to Comment
  • Kroger: The Earnings Dip Is A Buy Opportunity [View article]
    DAG1966

    Thanks for a nice article on one of my long-term holdings since the mid-20's. Congratulations on Editor's Pick status also.

    I might add that few people realize that Kroger has financial interests in farms and dairies across the country to support its vision of having a Kroger store within 5 miles of all US consumers. Because of these relationships, Kroger can get the freshest high-quality produce, meats and dairy products, sourced very near the stores. It even gets some organic products from its own farms, undercutting Whole Foods and Fresh Market by a wide margin...comparison shoppers can verify this. When it comes to those competitors, who simply buy from suppliers, we will see who eats whose lunch. I should also mention that Kroger is the largest florist in the US, a very high-margin business.

    Regards,

    Stan
    Dec 9, 2013. 06:30 PM | 2 Likes Like |Link to Comment
  • Ambarella - Momentum In Stock Outpaces Operational Improvements For This Well-Led Company [View article]
    Weird...author likes SODA with similar growth rates and $.30/per share in cash flow at $53, but is cautious about AMBA with$.73 in cash flow and $25 per share.

    AMBA net income would be about $2 per share without R & D expense, as the company is ramping up to introduce more industry-best products, and SODA is a one-gadget wonder.

    Oh well...good luck to all, but I know which horse I would bet on.
    Dec 9, 2013. 05:54 AM | 10 Likes Like |Link to Comment
  • Ambarella Knocks The Quarter Out Of The Park, More Upside Ahead [View article]
    AMBA gets the majority of its revenue from outside the US now, so obviously has room for expansion in the US and other industries. Although earnings are great, this is AFTER rather large expenditures in R & D which will keep the technology in front.
    Dec 6, 2013. 10:27 AM | 1 Like Like |Link to Comment
  • Two Crazy-Cheap $5 Stocks To Benefit From China's Initiatives For Its Middle Class [View article]
    GrowthGreek,

    I know both stocks you mention, and they are on the list for consideration. In general, I have a better comfort level with Chinese companies that have some of these 3 attributes: manageable accounts receivable, working relationship with government agencies in China and reputable international clients. I have seen otherwise good stocks shot down by not watching these areas. Regarding EVK, I think the fact that they sell products to large retailers world-wide offers some level of assurance that they can provide the efficiency and quality that I am looking for. Both XUE and EVK have operations in many areas within China, which tells me they know how to manage the government agencies at local levels on up. XUE actually was designated by The Ministry of Education as the leader to organize the signing of a Self-discipline Agreement for private tutoring groups in China.
    Dec 4, 2013. 09:13 PM | 1 Like Like |Link to Comment
  • Refreshing Our Best-Of-The-Best Dividend Portfolio [View article]
    galicianova

    I do not know what the year-end payout will be yet, but in the last 2 years it has averaged $.91 per share over and above the normal $.384 quarterly distribution. I am expecting about that much.

    That would give us a total annual distribution of about $2.45. Divide that by $34.75 today is a yield of 7.0%. If you divide by the price of $32.85 when the article was published, the yield is 7.5%.

    There is no guarantee that they will choose to distribute that amount, but it could be more, BME has more than enough undistributed income and gains to pay a distribution in line with the previous years.

    Hope that helps.
    Nov 28, 2013. 01:44 AM | Likes Like |Link to Comment
  • Finally, This High-Yield Microcap Is Helping The FDA Cut Approval Time [View article]
    risendragon

    There is a lot to like here:

    solid management
    recurring license revenue with 90%+ renewal rate
    justifiable price increases
    inside connections with FDA, EPA, and foreign agencies
    3% dividend and growing
    some institutional holders, with room for more

    However, it is not likely to be a trading stock as much as a solid long-term grower.
    Nov 25, 2013. 10:48 AM | Likes Like |Link to Comment
  • Two Crazy-Cheap $5 Stocks To Benefit From China's Initiatives For Its Middle Class [View article]
    GrowthGreek,

    Thanks for the suggestions for the Chinese market. I will add those to the list I am filtering. I know that there are mistakes and scams in this market, and it is good to distinguish between those. The short sellers are always a problem, even though often there is little reality to accusations. I look at any investment in these small Chinese companies as strictly a long-term proposition. In some cases, companies with some doubt overhang actually may be the better bargains, if you can get past the doubts. EVK has suffered some from an SEC sanction about a transaction between the company and a related party, which is probably a relatively insignificant and honest mistake. I am more concerned about smoke and mirror earnings and overvaluation of properties, etc. that some Chinese companies allow...investors really need to study what they are buying.

    I am still trying to figure out all the ramifications of the Chinese initiatives. One I just discovered is that the Chinese government will now require periodical testing of students' progress, instead of just annually. That will be a huge boon to XUE immediately, as their business has been very seasonal due to the once-a-year cramming. This will mean that tutoring needs will be identified quicker and more frequently.
    Nov 22, 2013. 02:46 PM | 2 Likes Like |Link to Comment
  • Finally, This High-Yield Microcap Is Helping The FDA Cut Approval Time [View article]
    Goalkick9,

    The company pretty much advised that the profit would be muted this quarter. This is what I included in the article:

    "SLP has announced that its fiscal fourth quarter, ending in September 2013, will be its 46th profitable quarter in the last 48, but I suspect the salary expense will reduce that profit in this quarter and the next."

    Also in the conclusion:

    "From a timing point of view, it is possible that profits will suffer some until spring of 2014."

    I look at SLP as a long-term holding, with the expectation that in time their simulation software will be the standard for companies seeking approval from FDA, EPA and other agencies. That is a big deal, but not an overnight event. Also, the revenue that they do have is pretty stable with a high level of renewals. Actually, I had to decide for me and clients to wait for a couple earnings announcements that may be mundane, or go ahead and start collecting dividends and stake out our position. It trades pretty thinly and can get away pretty quickly, so I am happy with our stake. This time next year could find SLP as a double-digit stock, and I just don't see a lot of downside. In the meantime the yield is good.

    Just my opinion...

    Stan
    Nov 19, 2013. 12:08 PM | Likes Like |Link to Comment
  • Finally, This High-Yield Microcap Is Helping The FDA Cut Approval Time [View article]
    Douglas,

    I think the culture of the company is directed by the management, and the production of income for stockholders is part of that. Management salaries are pretty reasonable, but they do own 41% of the stock, so I think they rely on the dividends for income also. SLP also has a good cash horde and no debt if they want to kick start growth. Like I said, I do think growth acceleration will come, but at a steady and deliberate pace. I am mostly a long-term investor so that is all fine with me.

    Thanks for reading my article.

    Stan
    Nov 6, 2013. 07:28 PM | Likes Like |Link to Comment
  • Finally, This High-Yield Microcap Is Helping The FDA Cut Approval Time [View article]
    Goalkick

    Thanks. I have been buried with some consulting, and I have a few articles in the 90% stage, but really waiting for a few factors to play out to verify my thesis on these investments.

    I was involved in helping a huge investment bank with salvaging one of its "toxic assets" in 2008-2009. I am writing a novel, based on that experience...lots of intrigue and villains. Anyway, it has taken me from the SA articles.

    Stan
    Nov 6, 2013. 07:15 PM | Likes Like |Link to Comment
  • A Microrecession Dead Cat Bounce? [View article]
    Besides the blatant political bias...the article is also has a faulty premise. A record number of companies are paying dividends, including irregular dividend amounts, rather than stable monthly payments. I would be shocked if there were not more dividend cuts.
    Oct 8, 2013. 10:48 AM | 1 Like Like |Link to Comment
COMMENTS STATS
214 Comments
157 Likes